Indivior PLC (LON:INDV)
798.00
+26.00 (3.37%)
Apr 25, 2025, 2:43 PM BST
Indivior Employees
As of December 31, 2024, Indivior had 1,051 total employees, including 1,030 full-time and 21 part-time employees. The number of employees decreased by 113 or -9.71% compared to the previous year.
Employees
1,051
Change (1Y)
-113
Growth (1Y)
-9.71%
Revenue / Employee
869.90K GBP
Profits / Employee
-46.10K GBP
Market Cap
963.14M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Oxford Nanopore Technologies | 1,315 |
Indivior News
- 1 day ago - A Look at Indivior's Upcoming Earnings Report - Benzinga
- 7 weeks ago - Decoding Indivior PLC (INDV): A Strategic SWOT Insight - GuruFocus
- 7 weeks ago - Two Seas Capital LP Reduces Stake in Indivior PLC - GuruFocus
- 7 weeks ago - Indivior Announces Further Changes to Board of Directors - PRNewsWire
- 2 months ago - UK's Indivior appoints Joe Ciaffoni as CEO - Reuters
- 2 months ago - Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer - PRNewsWire
- 2 months ago - Indivior gets FDA approval for label changes for Sublocade injection - Seeking Alpha
- 2 months ago - Indivior Announces FDA Approval of Label Changes for SUBLOCADE® (buprenorphine extended-release) Injection - PRNewsWire